Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02572986 | A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies | PHASE3 | COMPLETED | 250 | — | — | Sep 1, 2015 | Aug 1, 2016 | Oct 14, 2016 | 13 | United States, El Salvador +1 |
| Arm | Type | Description |
|---|---|---|
| Permethrin cream 5% | EXPERIMENTAL | Manufactured by Dr. Reddy's Laboratories, Ltd |
| Elimite™ Cream (permethrin) 5% | ACTIVE_COMPARATOR | Manufactured by Prestium Pharma, Inc |
| Name | Type | Description |
|---|---|---|
| Permethrin | DRUG | - |
Inclusion Criteria: 1. Signed Informed Consent that meets all criteria of current FDA regulations. 2. Male or non-pregnant, non-lactating female at least 2 years of age or older. 3. Diagnosis of active scabies by presence of a burrow and/or typical scabietic lesions at the classic sites of infestat...